Compare BDTX & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDTX | TORO |
|---|---|---|
| Founded | 2014 | 2022 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.8M | 106.2M |
| IPO Year | 2020 | 2022 |
| Metric | BDTX | TORO |
|---|---|---|
| Price | $2.60 | $8.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | 802.4K | ★ 1.2M |
| Earning Date | 05-08-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 36.86% |
| EPS Growth | ★ 130.71 | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $6.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.46 | $1.80 |
| 52 Week High | $4.94 | $8.50 |
| Indicator | BDTX | TORO |
|---|---|---|
| Relative Strength Index (RSI) | 46.92 | 82.82 |
| Support Level | $2.45 | $3.15 |
| Resistance Level | $2.79 | N/A |
| Average True Range (ATR) | 0.20 | 0.72 |
| MACD | -0.06 | 0.30 |
| Stochastic Oscillator | 7.26 | 81.17 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. The company operates in Handysize tanker segment.